Recent observational cohort studies report that 46%-57% of chemotherapy patients experience
Burning Mouth Syndrome, otherwise known as BMS, is defined as “an intraoral
Leduc, AB- March 29, 2022- PBG BioPharma Inc. (“PBG” or the “Company”),
Got a project?
We’re a team of scientists who are excited about unique ideas and
help natural health companies create amazing products.